Medical Marijuana, Inc. Celebrates Largest Revenue Month of 2022 in April, Japan Division Achieves Best Revenue Month in History of the Company
SAN DIEGO, CA, May 12, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Medical Marijuana, Inc. ( OTC: MJNA ) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that in April, the Company has achieved its largest revenue month of 2022 and its subsidiary Kannaway® has achieved its largest revenue month in the company’s history in its Japan division. Leading analyst firm Research and Markets predicts that the global cannabidiol (CBD) oil market is expected to reach $5.3 billion by 2025 with Asia-Pacific as one of the fastest-growing regions. In fact, Japan’s CBD market is projected to become the second-largest CBD market in Asia . “Medical Marijuana, Inc. continues to build on its international footprint in 2022 and we are proud to be the leader in creating free access to cannabis-based ...